AddLife AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AddLife AB with three other
miscellaneous service companies in Europe:
sales of 1.82 billion Danish Kroner [US$297.10 million]
of which 100%
Pharma Mar SA
(180.95 million Euro [US$220.40 million]
of which 62%
was Biotech Sector), and
Bachem Holding AG
based in Switzerland
(236.48 million Swiss Francs [US$244.30 million]
of which 89%
was Active Pharmaceutical Ingredients).